Keay Nakae
Stock Analyst at Chardan Capital
(3.42)
# 2,405
Out of 4,683 analysts
616
Total ratings
41%
Success rate
3%
Average return
Main Sectors:
Stocks Rated by Keay Nakae
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRME Prime Medicine | Maintained: Buy | $7 | $3.58 | +95.53% | 1 | Aug 25, 2026 | |
| SLN Silence Therapeutics | Maintained: Buy | n/a | $13.53 | - | 19 | Aug 16, 2026 | |
| PMN ProMIS Neurosciences | Maintained: Buy | $20 → $33 | $14.46 | +128.22% | 2 | Aug 13, 2026 | |
| MGX Metagenomi Therapeutics | Maintained: Buy | $5 | $1.22 | +309.84% | 1 | Aug 10, 2026 | |
| BME: PHM Pharma Mar, S.A. | Maintained: Buy | €100.00 | €83.60 | +19.62% | 9 | Aug 9, 2026 | |
| KRRO Korro Bio | Reiterated: Buy | $15 | $13.68 | +9.65% | 6 | Aug 6, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Maintained: Buy | $115 | $89.12 | +29.04% | 49 | Aug 4, 2026 | |
| STOK Stoke Therapeutics | Maintained: Buy | $35 | $33.09 | +5.77% | 2 | Aug 3, 2026 | |
| DYN Dyne Therapeutics | Maintained: Buy | $40 → $38 | $26.36 | +44.16% | 20 | Jul 29, 2026 | |
| EPA: ALSEN Sensorion SA | Initiated Coverage: Buy | €1.00 | €0.27 | +266.30% | 1 | Jul 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €0.08 | €0.12 | -32.20% | 3 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $1.43 | +249.65% | 7 | Jul 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $3 | $2.35 | +27.66% | 40 | Jun 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $16 | $3.88 | +312.37% | 20 | Jun 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6.5 | $4.20 | +54.76% | 1 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $4.87 | +187.47% | 19 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $425 | $239.00 | +77.82% | 51 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $36.53 | -17.88% | 4 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | ¥800 | ¥284 | +181.69% | 1 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $5.26 | +280.23% | 12 | Mar 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $2.5 → $45 | $1.75 | +2,471.43% | 6 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $0.505 | +7,820.79% | 1 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €10.00 → €5.00 | €0.71 | +601.26% | 5 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 → $85 | $113.72 | -25.26% | 2 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $25 → $6 | $4.76 | n/a | 19 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $11.22 | n/a | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.00001 | n/a | 4 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.22 | n/a | 20 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.73 | n/a | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $12 | $0.377 | n/a | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4.5 → $5 | $5.19 | n/a | 47 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $1.81 | n/a | 7 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $8 | $2.92 | n/a | 14 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 13 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $16.84 | n/a | 16 | Dec 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $16.18 | n/a | 1 | Mar 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $5.97 | n/a | 31 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $9.21 | n/a | 5 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $76.99 | n/a | 6 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.131 | n/a | 18 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $9.43 | n/a | 1 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $100 → $50 | $0.0001 | n/a | 8 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.26 | n/a | 15 | Sep 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.12 | n/a | 15 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.81 | n/a | 8 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2,533.00 | n/a | 9 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $15.83 | n/a | 9 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 6 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $9.63 | n/a | 5 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 → $4.5 | $1.41 | n/a | 9 | Jun 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.7733 | n/a | 2 | Nov 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $2 | $4.30 | n/a | 11 | Jul 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $149.66 | n/a | 1 | Mar 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 2 | Jan 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $24.26 | n/a | 3 | Jun 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $9.10 | n/a | 1 | Jun 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.3 → $4.5 | $0.9199 | n/a | 3 | Feb 16, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $2.59 | n/a | 3 | Dec 6, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $6.78 | n/a | 1 | Aug 23, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2.25 | $2.64 | n/a | 1 | Aug 12, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2.25 → $2 | $0.0001 | n/a | 4 | Jul 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $6 | $1.52 | n/a | 4 | Mar 28, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $1.56 | n/a | 1 | Dec 3, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4 | $3.02 | n/a | 1 | Aug 6, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $100 → $18 | $0.0002 | n/a | 3 | May 15, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $4.15 | n/a | 1 | Oct 7, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5.5 | $0.0001 | n/a | 1 | Jul 3, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $2.3 | $0.2432 | n/a | 1 | Jun 25, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $42.44 | n/a | 1 | May 16, 2012 |
Prime Medicine
Aug 25, 2026
Maintained: Buy
Price Target: $7
Current: $3.58
Upside: +95.53%
Silence Therapeutics
Aug 16, 2026
Maintained: Buy
Price Target: n/a
Current: $13.53
Upside: -
ProMIS Neurosciences
Aug 13, 2026
Maintained: Buy
Price Target: $20 → $33
Current: $14.46
Upside: +128.22%
Metagenomi Therapeutics
Aug 10, 2026
Maintained: Buy
Price Target: $5
Current: $1.22
Upside: +309.84%
Pharma Mar, S.A.
Aug 9, 2026
Maintained: Buy
Price Target: €100.00
Current: €83.60
Upside: +19.62%
Korro Bio
Aug 6, 2026
Reiterated: Buy
Price Target: $15
Current: $13.68
Upside: +9.65%
Arrowhead Pharmaceuticals
Aug 4, 2026
Maintained: Buy
Price Target: $115
Current: $89.12
Upside: +29.04%
Stoke Therapeutics
Aug 3, 2026
Maintained: Buy
Price Target: $35
Current: $33.09
Upside: +5.77%
Dyne Therapeutics
Jul 29, 2026
Maintained: Buy
Price Target: $40 → $38
Current: $26.36
Upside: +44.16%
Sensorion SA
Jul 19, 2026
Initiated Coverage: Buy
Price Target: €1.00
Current: €0.27
Upside: +266.30%
Jul 15, 2026
Maintained: Hold
Price Target: €0.08
Current: €0.12
Upside: -32.20%
Jul 1, 2026
Reiterated: Buy
Price Target: $5
Current: $1.43
Upside: +249.65%
Jun 25, 2026
Reiterated: Buy
Price Target: $4 → $3
Current: $2.35
Upside: +27.66%
Jun 16, 2026
Reiterated: Buy
Price Target: $14 → $16
Current: $3.88
Upside: +312.37%
Jun 10, 2026
Initiated Coverage: Buy
Price Target: $6.5
Current: $4.20
Upside: +54.76%
May 12, 2026
Maintained: Buy
Price Target: $14
Current: $4.87
Upside: +187.47%
May 1, 2026
Reiterated: Buy
Price Target: $425
Current: $239.00
Upside: +77.82%
Apr 21, 2026
Maintained: Buy
Price Target: $30
Current: $36.53
Upside: -17.88%
Apr 7, 2026
Initiated Coverage: Buy
Price Target: ¥800
Current: ¥284
Upside: +181.69%
Mar 12, 2026
Maintained: Buy
Price Target: $20
Current: $5.26
Upside: +280.23%
Feb 24, 2026
Upgraded: Buy
Price Target: $2.5 → $45
Current: $1.75
Upside: +2,471.43%
Jan 5, 2026
Maintained: Buy
Price Target: $40
Current: $0.505
Upside: +7,820.79%
Sep 30, 2025
Maintained: Buy
Price Target: €10.00 → €5.00
Current: €0.71
Upside: +601.26%
Sep 25, 2025
Maintained: Buy
Price Target: $60 → $85
Current: $113.72
Upside: -25.26%
May 8, 2025
Downgraded: Hold
Price Target: $25 → $6
Current: $4.76
Upside: n/a
Dec 20, 2024
Rated: Hold
Price Target: n/a
Current: $11.22
Upside: n/a
Dec 20, 2024
Rated: Hold
Price Target: n/a
Current: $0.00001
Upside: n/a
Dec 20, 2024
Rated: Hold
Price Target: n/a
Current: $1.22
Upside: n/a
Dec 20, 2024
Rated: Hold
Price Target: n/a
Current: $1.73
Upside: n/a
Dec 20, 2024
Maintained: Hold
Price Target: $12
Current: $0.377
Upside: n/a
Nov 19, 2024
Maintained: Buy
Price Target: $4.5 → $5
Current: $5.19
Upside: n/a
Nov 18, 2024
Reiterated: Buy
Price Target: $6
Current: $1.81
Upside: n/a
Nov 12, 2024
Maintained: Buy
Price Target: $10 → $8
Current: $2.92
Upside: n/a
Mar 14, 2024
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Dec 12, 2023
Rated: Hold
Price Target: n/a
Current: $16.84
Upside: n/a
Mar 9, 2023
Reiterated: Buy
Price Target: n/a
Current: $16.18
Upside: n/a
Feb 17, 2023
Rated: Hold
Price Target: n/a
Current: $5.97
Upside: n/a
Feb 17, 2023
Rated: Hold
Price Target: n/a
Current: $9.21
Upside: n/a
Feb 17, 2023
Rated: Hold
Price Target: n/a
Current: $76.99
Upside: n/a
Feb 17, 2023
Rated: Hold
Price Target: n/a
Current: $0.131
Upside: n/a
Feb 6, 2023
Reiterated: Buy
Price Target: n/a
Current: $9.43
Upside: n/a
Nov 16, 2022
Downgraded: Hold
Price Target: $100 → $50
Current: $0.0001
Upside: n/a
Sep 30, 2022
Rated: Hold
Price Target: n/a
Current: $1.26
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $1.12
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $1.81
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $2,533.00
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $15.83
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $9.63
Upside: n/a
Jun 10, 2021
Reiterated: Hold
Price Target: $8 → $4.5
Current: $1.41
Upside: n/a
Nov 20, 2020
Rated: Hold
Price Target: n/a
Current: $0.7733
Upside: n/a
Jul 30, 2020
Rated: Hold
Price Target: $2
Current: $4.30
Upside: n/a
Mar 23, 2020
Reiterated: Buy
Price Target: n/a
Current: $149.66
Upside: n/a
Jan 28, 2020
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Jun 10, 2019
Rated: Hold
Price Target: n/a
Current: $24.26
Upside: n/a
Jun 10, 2019
Rated: Hold
Price Target: n/a
Current: $9.10
Upside: n/a
Feb 16, 2017
Maintained: Buy
Price Target: $3.3 → $4.5
Current: $0.9199
Upside: n/a
Dec 6, 2016
Maintained: Buy
Price Target: $6
Current: $2.59
Upside: n/a
Aug 23, 2016
Maintained: Buy
Price Target: $4
Current: $6.78
Upside: n/a
Aug 12, 2016
Reiterated: Buy
Price Target: $2.25
Current: $2.64
Upside: n/a
Jul 8, 2016
Maintained: Buy
Price Target: $2.25 → $2
Current: $0.0001
Upside: n/a
Mar 28, 2016
Reiterated: Buy
Price Target: $12 → $6
Current: $1.52
Upside: n/a
Dec 3, 2014
Initiated Coverage: Buy
Price Target: $16
Current: $1.56
Upside: n/a
Aug 6, 2014
Downgraded: Hold
Price Target: $4
Current: $3.02
Upside: n/a
May 15, 2014
Downgraded: Hold
Price Target: $100 → $18
Current: $0.0002
Upside: n/a
Oct 7, 2013
Initiated Coverage: Buy
Price Target: $13
Current: $4.15
Upside: n/a
Jul 3, 2013
Reiterated: Buy
Price Target: $5.5
Current: $0.0001
Upside: n/a
Jun 25, 2013
Initiated Coverage: Buy
Price Target: $2.3
Current: $0.2432
Upside: n/a
May 16, 2012
Initiated Coverage: Buy
Price Target: n/a
Current: $42.44
Upside: n/a